Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Systemic and cell type-specific gene expression patterns in scleroderma skin.

Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12319-24. Epub 2003 Oct 6.

2.

Molecular subsets in the gene expression signatures of scleroderma skin.

Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML.

PLoS One. 2008 Jul 16;3(7):e2696. doi: 10.1371/journal.pone.0002696. Erratum in: PLoS ONE. 2008;3(10). doi: 10.1371/annotation/05bed72c-c6f6-4685-a732-02c78e5f66c2.

3.

Cell-type specific gene expression profiles of leukocytes in human peripheral blood.

Palmer C, Diehn M, Alizadeh AA, Brown PO.

BMC Genomics. 2006 May 16;7:115.

4.

Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.

Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, Ahsan H.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1367-75.

5.

Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs.

Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, Sherman S, Dybkaer K, Zhou G, Eudy JD, Delabie J, McKeithan TW, Chan WC.

BMC Immunol. 2004 Sep 15;5:20.

6.

Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.

Coelho LF, de Oliveira JG, de Oliveira DB, Guedes AC, Lanna CC, Prados RZ, Ferreira PC, Bonjardim CA, Kroon EG.

Arch Dermatol Res. 2007 Aug;299(5-6):259-62. Epub 2007 Jun 1.

PMID:
17541615
7.

Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.

Sawaya HH, Jimenez SA, Artlett CM.

Rheumatology (Oxford). 2004 Aug;43(8):965-8. Epub 2004 Jun 15.

PMID:
15199216
9.

Affected and non-affected skin fibroblasts from systemic sclerosis patients share a gene expression profile deviated from the one observed in healthy individuals.

Fuzii HT, Yoshikawa GT, Junta CM, Sandrin-Garcia P, Fachin AL, Sakamoto-Hojo ET, Donadi EA, Passos GA, Andrade LE.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):866-74.

PMID:
19032821
10.

Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers.

Bos CL, van Baarsen LG, Timmer TC, Overbeek MJ, Basoski NM, Rustenburg F, Baggen JM, Thiesen HJ, Dijkmans BA, van der Pouw Kraan TC, Voskuyl AE, Verweij CL.

Genes Immun. 2009 Apr;10(3):210-8. doi: 10.1038/gene.2008.98. Epub 2009 Jan 8.

PMID:
19129850
11.

Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.

Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.

Arthritis Rheum. 2005 Apr;52(4):1248-58.

12.

The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.

Corriveau MP, Boufaied I, Lessard J, Chabaud S, Senécal JL, Grodzicky T, Chartier S, Raymond Y, Moulin VJ.

J Pathol. 2009 Mar;217(4):534-42. doi: 10.1002/path.2482.

PMID:
19086038
13.

Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.

Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C.

Arthritis Rheum. 2007 Oct;56(10):3459-67.

14.

HLA-G expression in the skin of patients with systemic sclerosis.

Wastowski IJ, Sampaio-Barros PD, Amstalden EM, Palomino GM, Marques-Neto JF, Crispim JC, Biral AC, Rassi DM, Carosella ED, Moreau P, Donadi EA.

J Rheumatol. 2009 Jun;36(6):1230-4. doi: 10.3899/jrheum.080552. Epub 2009 Apr 15.

PMID:
19369464
15.

Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.

Lawrence A, Khanna D, Misra R, Aggarwal A.

Dermatol Online J. 2006 Jan 27;12(1):2.

16.

The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.

Davies CA, Jeziorska M, Freemont AJ, Herrick AL.

Hum Pathol. 2006 Feb;37(2):190-7. Epub 2005 Dec 15.

PMID:
16426919
17.

cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies.

Zhou X, Dimachkie MM, Xiong M, Tan FK, Arnett FC.

Med Sci Monit. 2004 Jul;10(7):BR191-7. Epub 2004 Jun 29.

PMID:
15232492
18.

Early T cell activation in the skin from patients with systemic sclerosis.

Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, Sakkas L.

Ann Rheum Dis. 2005 Aug;64(8):1233-5.

19.
20.

Differential expression of HOX genes upon activation of leukocyte sub-populations.

Morgan R, Whiting K.

Int J Hematol. 2008 Apr;87(3):246-9. doi: 10.1007/s12185-008-0057-8. Epub 2008 Mar 5.

Supplemental Content

Support Center